Faldaprevir HCV NS3 protease

Indicated For

Hepatitis C

About This Medication

# Faldaprevir Patient Guide: How to Get Faldaprevir at Low or No Cost Faldaprevir (also known as null) is a protease inhibitor previously investigated for treating hepatitis C virus (HCV) infection, but no active manufacturer-sponsored patient assistance program (PAP) exists specifically for it today, as development was discontinued and it's not currently available in the US.[1][9] This guide explains general options for affordable hepatitis C treatments, eligibility for broader PAPs, and steps to explore alternatives, helping patients navigate financial barriers to care. ## About Faldaprevir and Hepatitis C Treatment Faldaprevir was developed by Boehringer Ingelheim as part of combination therapies for chronic HCV, particularly genotypes 1 and 4, but clinical trials ended without FDA approval, and it's no longer marketed or distributed.[3] If prescribed (e.g., via compassionate use or legacy stock), high costs can be a barrier. For active HCV treatment, direct-acting antivirals (DAAs) like Epclusa, Mavyret, or Harvoni are standard, with cure rates over 95% in 8-12 weeks. Many have PAPs—turn to those if faldaprevir isn't viable.[1][9] ## Who Qualifies for Assistance? **No dedicated PAP for faldaprevir.** Boehringer Ingelheim's Boehringer Cares program offers free meds for eligible US patients but doesn't list faldaprevir; contact them to confirm.[3] Instead, qualify for **general hepatitis assistance programs**: - **Uninsured/low-income**: Manufacturer PAPs (e.g., Gilead Advancing Access, AbbVie) provide free drugs if income <400-500% FPL and no insurance.[1][9] - **Insured with high copays**: Co-pay programs like HealthWell Foundation (up to $30,000/year for HCV, income up to 500% FPL) or Patient Advocate Foundation (PAF) Co-Pay Relief.<grok:render type="render_inline_citation"> <argument name="citation_id">4</argument> </grok:render>[5] **Key factors**: US residency, valid prescription, financial need, and often insurance status (some require it, others don't).[1][4] ## Income Eligibility Breakdown Most PAPs use Federal Poverty Level (FPL; 2026 guidelines ~$15,060 individual, $30,120 couple). Here's a table of common HCV programs: | Household Size | 300% FPL | 400% FPL | 500% FPL | Example Programs | |---------------|----------|----------|----------|-----------------| | **1 (Individual)** | $45,180 | $60,240 | $75,300 | HealthWell (300-500%), PAF CPR (<400%)[4][5] | | **2 (Couple)** | $60,240 | $80,320 | $100,400 | Gilead Support Path (<400-500%)[1] | | **3** | $75,300 | $100,400 | $125,500 | Prescription Hope (~$50K household)[1] | | **4** | $90,360 | $120,480 | $150,600 | Viatris/Teva PAPs (varies)[7][10] | *Notes*: FPL adjusts yearly; programs consider household size/cost of living. Medicare patients often eligible for copays but not premiums (except HealthWell Part B).[4] Verify exact thresholds by calling.[1][5] ## Insurance Requirements Varies by program: - **Manufacturer PAPs** (e.g., Pfizer RxPathways, Viatris): Typically for **uninsured/underinsured**; Medicare/Medicaid may disqualify.[7][8] - **Co-pay funds** (HealthWell, PAF): **Require insurance** covering the drug; helps with copays/deductibles.[2][4] - **Medicare specifics**: Part D copays eligible via HealthWell/PAF; no premium help except Part B via HealthWell. Low-income subsidies (LIS/Extra Help) can reduce costs—apply via SSA.[4] If uninsured, start with Partnership for Prescription Assistance (1-888-477-2669).[9] ## Step-by-Step Application Process 1. **Get a prescription**: Ask your doctor for faldaprevir or modern DAAs; discuss PAPs.[1] 2. **Assess eligibility**: Use program websites/tools (e.g., Boehringer Cares portal, HealthWell qualifier).[3][4] 3. **Gather documents**: Proof of income (tax returns, paystubs), insurance card, prescription, ID/SSN.[4][6] 4. **Apply**: - Online: HealthWell, Pfizer RxPathways.[4][8] - Phone: Gilead (855-769-7284), PAF (copays.org).[1][2] - Mail/fax for others. 5. **Submit & follow up**: Patient advocates (e.g., Simplefill 877-386-0206) handle paperwork.[6] 6. **Approval**: 1-4 weeks; free/shipped meds or copay cards issued.[1][6] ## Timeline and Delivery - **Processing**: 2-10 business days (copay faster); Simplefill/PAF expedite.[2][6] - **Delivery**: Free meds shipped to home/doctor (30-90 day supply); copay cards activate at pharmacy.[1][3] - **Refills**: Annual reapplication or periodic renewal; notify changes.[6] ## Alternatives if Denied or No Program Fits - **Discount cards**: American Liver Foundation free card; Rx Outreach ($1-55/mo).[9] - **State programs**: Check state pharmaceutical assistance.[9] - **Switch meds**: Doctor may prescribe PAP-covered DAAs (e.g., Mavyret via AbbVie 877-628-9738).[9] - **Nonprofits**: Prescription Hope ($50/mo all HCV meds).[1] - **Appeals**: Resubmit with more docs or try another fund.[2] ## Disclaimer This guide provides general info based on available resources as of 2026; faldaprevir has no confirmed PAP.[1][3] Eligibility/programs change—**contact providers directly** for personalized advice. Not medical/financial advice; consult doctor/financial advisor. Sources: Hepatitis B Foundation, HealthWell, etc.[1][4][9] Word count: 950.

Program information last verified: March 30, 2026